Actively Recruiting
Self-hypnosis Training for Chronic Pain Management
Led by Ciusss de L'Est de l'Île de Montréal · Updated on 2025-01-28
60
Participants Needed
1
Research Sites
95 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Title: Self-hypnosis training in chronic pain management: A pilot study Our primary objective concerns the effect of hypnosis intervention on change in 24h pain between T0 (pre-intervention) and T4 (3-month follow-up). The secondary objectives concern the effects of the intervention on (i) change in 24h pain between T0 and T5 (6-month follow-up), (ii) changes from T0 in measures of the functional impact of pain, (iii) changes from T0 in anxiety-depression scores and (iv) changes from T0 in quality of life. The study design is a Randomized efficacy pilot study. The study focuses on patients practicing self-hypnosis within HMR groups. The study population is pain clinic patients. The sample size is 60 pain clinic patients. Study duration: February 2024 - December 2024. Center responsible for the study: Centre de Recherche de l'Hôpital Maisonneuve-Rosemont (CR-HMR) - CEMTL, Montreal, Quebec, Canada. Adverse events: none expected.
CONDITIONS
Official Title
Self-hypnosis Training for Chronic Pain Management
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be 18 years of age or older
- Have chronic pain lasting at least 3 months
- Have a pain intensity of at least 4 on a 0 to 10 scale over the last 24 hours
- Be able to read, speak, and understand French
- Have internet access and be able to participate in online group sessions and complete questionnaires
- Have received one of the study diagnoses confirmed by medical records or physician
- Have participated in the self-hypnosis training program within the past year and agree to take part in research interviews
You will not qualify if you...
- Have deafness or severe cognitive impairment that makes communication difficult
- Have current or recent psychiatric instability such as active suicidal thoughts or psychosis that could interfere with participation as evaluated by a clinical psychologist
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
5415 Bd de l'Assomption
Montreal, Quebec, Canada, H1T 2M4
Actively Recruiting
Research Team
D
David Ogez
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here